Download PDF
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Glycemic control, the unconsidered outcome in the treatment of nonalcoholic fatty liver disease
Diego García-Compeán; Emanuela Orsi; Tsutomu Nishida; Ramesh Kumar;
10.1016/j.aohep.2021.100648
Effect of bariatric endoscopy on liver fibrosis and steatosis and the course of NAFLD ¿ a prospective interventional study
Adam Va¿ura; Ev¿en Machytka; Ond¿ej Urban; Jitka Machá¿ková; Lubomír Pavliska; Zden¿k Berka; Zden¿k ¿vagera; Marek Bu¿ga;
10.1016/j.aohep.2024.101765
Updated recommendations for the management of metabolic dysfunction¿associated steatotic liver disease (MASLD) by the Latin American working group.
Luis Antonio Diaz; Juan Pablo Arab; Francisco Idalsoaga; Javiera Perelli; Javier Vega; Melisa Dirchwolf; Javiera Carreño; Bárbara Samith; Cynthia Valério; Rodrigo Oliveira Moreira; Mónica Acevedo; Javier Brahm; Nelia Hernández; Adrian Gadano; Claudia P. Oliveira; Marco Arrese; Graciela Castro-Narro; Mario G. Pessoa;
10.1016/j.aohep.2025.101903